Devyser and QIAGEN collaborate on pre-analytical workflow for fetal RHD screening
Fetal derived cell-free DNA (cfDNA) is a key analyte for determining fetal RHD status in plasma...
Instructions for use
Enter access code found in the lower right corner of the label on the kit box.
Certificates
Download a specific Batch Release Certificate (BRC) below.
Guidelines and handbooks (2)
Product information (0)
Software settings (0)
Safety data sheets (3)
Data tables (0)
Enter access code found in the lower right corner of the label on the kit box.
Approval of Devyser’s RHD product in Canada
Devyser is today announcing that its product for non-invasive fetal RHD testing has been granted...
Devyser Diagnostics AB publishes quarterly report for the period January to March 2023
“The first quarter of the year saw continued strong growth, record gross margin and the launching...
Devyser’s clinical laboratory in Atlanta receives CLIA certification
Devyser is today announcing that the company’s clinical testing laboratory in Roswell in Atlanta,...
Data analysis made easy
Fast and effective test data analysis is crucial to achieving accurate outcomes and efficient workflows.
Dedicated software in our products makes analyzing test results quick, easy and trouble-free. For users, this means a streamlined end-to-end process with unmatched reliability and transparency.
